Related Experiment Video
Updated: Mar 13, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Challenges and opportunities in the treatment of ventilator-associated pneumonia
Matthew P Schreiber1, Andrew F Shorr1
1a Department of Internal Medicine , Section of Pulmonary Disease & Critical Care , 110 Irving St NW, Washington , DC , USA.
Introduction:
Ventilator-associated pneumonia (VAP) is a distinct clinical entity characterized by an onset after 48 hours of the application of mechanical ventilation (MV). Protocols exist to aid in the prevention of VAP, but this infection carries a devastating impact on patient morbidity and potentially mortality. Areas covered: In this review we present key concepts from existing guidelines to aid clinicians. Challenges remain in defining this disease and, most importantly appropriate empiric antimicrobial treatment is the main determinant of outcome. We highlight that the selection of initial antibiotics is critical, as VAP can by caused by a broad array of drug resistant organisms (DROs), the appropriate duration of treatment for VAP is an evolving concept, but may, in part, be guided by biomarkers, and provide focus on diagnostic challenges, initial therapies and treatment strategies for VAP. Both traditional and novel antimicrobials are presented, including developments in the modes of delivery. Expert commentary: The clinical approach to VAP continues to evolve. Recent evidence regarding the changes in microbiology, diagnostics approaches, and treatment strategies for VAP are important for clinicians to remain informed of to provide optimal patient care.
Insights
Ventilator-associated pneumonia (VAP) requires careful management. Optimizing empiric antibiotic treatment and diagnostic strategies is crucial for improving patient outcomes and reducing mortality from this serious respiratory infection.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pulmonology
Background:
- Ventilator-associated pneumonia (VAP) is a significant complication following mechanical ventilation (MV), impacting patient morbidity and mortality.
- Existing prevention protocols for VAP are available, yet challenges persist in disease definition and effective treatment.
Purpose of the Study:
- To review key concepts from existing guidelines for VAP management.
- To highlight challenges in VAP diagnosis and the critical role of empiric antimicrobial therapy.
- To discuss evolving treatment strategies, including novel antimicrobials and biomarker-guided duration.
Main Methods:
- Review of existing guidelines and current literature on VAP.
- Analysis of diagnostic challenges and therapeutic approaches.
- Presentation of traditional and novel antimicrobial agents and delivery methods.
Main Results:
- Empiric antimicrobial treatment is a primary determinant of VAP patient outcomes.
- Drug-resistant organisms (DROs) frequently cause VAP, necessitating careful antibiotic selection.
- Biomarkers may guide the evolving concept of appropriate VAP treatment duration.
Conclusions:
- The clinical approach to VAP is continuously evolving.
- Staying informed about changes in VAP microbiology, diagnostics, and treatment is essential for optimal patient care.
- Effective management of VAP relies on informed diagnostic and therapeutic strategies, particularly concerning initial antibiotic choice.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Mechanical Ventilation I: Indication and Settings

